BRIEF—Allergan acquires Envy Medical

Best known as the maker of Botox (onabotulinumtoxinA), Ireland-headquartered Allergan today announced it has completed the acquisition of Envy Medical, a privately held company with proprietary technology in skin resurfacing.

Financial terms of the deal were not disclosed.

"The acquisition of Envy Medical's Dermalinfusion reinforces our commitment to skin care and to offering a full range of solutions for Allergan customers and consumers. The breakthrough technology for skin resurfacing appeals to millennials and their focus on skin quality and is a perfect opportunity for Allergan to help our healthcare providers capture new patients for this and other medical aesthetic procedures," said Carrie Strom, senior vice President, US Medical Aesthetics at Allergan.

In addition to Dermalinfusion systems and serums, Envy offers a complete line of proprietary, take-home skin care products promoting healthy skin.

These products will further complement Allergan's SkinMedica portfolio of innovative skin care products.